Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Your share numbers don’t jive with the market cap amount
Monk, the probability of attaining $26 from the current status would be given low odds by many observers here, but if we had a LBPH or TPST like movement in a wild trading day then anything is possible. Some burnouts here are ready to bail at $2-4
Dancing, if someone completely new to Amarin and the EPA molecule were to read all the positive comments from your post below there would be tripping over one another and a mad rush to invest in this potential blockbuster drug with all sorts of medical benefits, yet here we are under cash value. Beyond mind bending
Maybe this product is for the anticipated combo pill and then it will be encapsulated?
Might be wishful thinking on my part, but something has to change in our favor this year.
Bird: “I imagine a lot of investors are betting that Amarin fails to win approval of the share buyback or that the recent revelation that 25 percent of its revenues could go out the window on July 1 offsets any positive effect of a buyback.”
Those “investors”, they’re called Shorts.
“Not sure” what you’re trying to say Bob. What was made public months ago? There’s been no official confirmation of any buybacks occurring
Way to explain yourself shadolane.
4 brief sentences of nothing
Newman, care to add up how many days just one entity would need to have allegedly scooped 30M shares in a vacuum? Beyond highly doubtful, but creative thinking
“Cancellation of share premium account” means approval of share purchases? Typical legal jargon 101 confusion
Unbelievable how poor the math is with some posters when thumbing a post regarding AMRN cash, after the buybacks, or the Sarissa share count total that’s all over the map for some. Take your pick
There were BO rumors in October of ‘12 (that’s when I first bought in) and it went from $11 to $14 but was “Z” really trying to sell 12 years ago? How does anyone really know or verify M&A until it actually happens
Is that like saying Blue Horse Shoe likes Annicot Steel?
Thanks Dr. Steve for your concern and bashing of V over the years. Scorned much?
Why don’t you just f’in sell and go buy shares in Wall Mart or McDonald’s. You are beyond tiring. Who is your intended listener on these message boards, Mother Hen?
This Ihub board has been told it can be anywhere from under 24 hours (rule 36 beat down) to a few months from the orals.
Total guessing game
Are you a shareholder or the board contrarian? Anything you do like about AMRN?
So using your logic, only the insider’s shares that they acquire and hold going forward are going to be worth anything at a later date? Any retail investor who owns shares won’t have any equity in their shares? Is that what you’re fear mongering about today?
Date of patent issued: 2/27/24
Thank you for the post MA52TA
The 1A wins several years ago ultimately turned out to be worthless hubris for AMRN. I’m sure everyone here would trade those hollow victories for anything court related post 2018.
Countless millions of dollars spent on defending this one drug company.
For CAFC not to remand back to District Court would be insulting and inexcusable.
To have gotten Dyk and Reyna twice is statistically a problem and just reeked of a judicial hatchet job,as evidenced by what eventually happened.
Thank you Skipperdog…Oral arguments on 4/2/24 @ 10:00 am for Hikma case. Not able to be delayed/rescheduled so it’s happening. 15 minutes for each side.
Saw steven1x post on Stocktwits about this
I will not nuke that premonition of yours. I am all for it, and then some. We need a new digit in front of the decimal point re: pps.
Commercial would cost the same amount (approx. $7M) as to what the previous jackals spent to defend against Sarissa proxy last year.
Given the choice, I’d take the 30 sec. random plug to let the world know about V. It’s not happening this evening on our screens, but an easy cost comparison to make.
Throw in some condescending comments and after the facts know it all approach and he’ll receive “the hate” comments year after year. He outwore his ability to connect with readers years ago.
JR, you really do like to play Switzerland on these message boards and, well, the reply comments you get are self explanatory.
Rose, great question. That would be a good discussion topic for Holt to answer at any time…I wouldn’t mind tomorrow morning
DAR, let’s clear some things up.
The stock had been in the 20’s for awhile before they shockingly announced a 22.2M share cash grab at $18. GS could have probably done this $2-5 higher but they and AMRN settled on $18 a share for a $400M bump in rainy day cash. It’s kept the company alive. Screw GS
Oh, so glad you’d be happy for it to “stay above 1 and climb on good news.”
Do you honestly think that Holt, or Denner, or anyone with a brain at AMRN is going to sign off on a R/S? Such an idiotic comment to post, but not surprising from some of your previous gems.
To Dusty and any other recent newcomer: Read months of previous posts and make sure your BS filter is clean and operational. It’s a steady study as to what’s going on and who is legit vs. misleading. Not sure about how many gp doctors on this site: Optometrist (1)…..
I have no idea why this would all take 2 more years to make it happen? That’s an eternity in Amarin time
What do you care, you don’t even own shares
Remind us all why you post here?
Were you two boobs in a scotch ad together
No drunk, just a Muppet in the balcony calling out repeats. I tried to beat you to your schtick with the inane math conversions and $5 break even crap. It was getting old, just like all of us long timers here. Feel free to pull out at $5 if you choose. No one cares about one’s unverified cost averages or sharecounts, for that matter.
Oh, allow me. “ if we close like this 17 more times in a row we will get to my $5 price where I will sell all prematurely and then bitch when it goes higher and is taken over” -Main
DAR, you nailed it.
His approach is Eyeore style. Thumb out the first thought (with no filter of Trust but verify), spoon feed other naysayers on the boards and then end a post with “I hope I’m wrong”
You are an unsolicited wet blanket on these boards
It’s always nice to wake up to good AMRN Saturday morning news… regarding Vascepa Medicare coverage the weekly prescription numbers are really going to important and sorely missed/needed.
Nothing has been confirmed, verified or validated from yours or NS prematurely posting a week ago. What part of waiting for clinical trial.gov don’t you understand?
Your hubris is beyond comprehension.
What an egotistical post you’ve made. Take your stick and ball and get lost. Your “efforts” have led to nothing more than conjecture. Bye bye